Aims: The pivotal ATLANTA first-in-man study showed the promising safety and efficacy profile of the novel Catania™ stent in a population with ~20% American College of Ca
Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com